These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 12003179

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.
    Violin M, Forbici F, Cozzi-Lepri A, Velleca R, Bertoli A, Riva C, Giannella S, Manconi PE, Lazzarin A, Pasquinucci S, Tacconi L, Carnevale G, Mazzotta F, Bonazzi L, Montroni M, Chirianni A, Capobianchi M, Ippolito G, Moroni M, Perno CF, D'Arminio-Monforte A, I.CO.N.A. Study Group. Italian Cohort of Antiretroviral Naive patients.
    J Biol Regul Homeost Agents; 2002; 16(1):37-43. PubMed ID: 12003172
    [Abstract] [Full Text] [Related]

  • 3. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
    Ghosn J, Pellegrin I, Goujard C, Deveau C, Viard JP, Galimand J, Harzic M, Tamalet C, Meyer L, Rouzioux C, Chaix ML, French PRIMO Cohort Study Group (ANRS CO 06).
    AIDS; 2006 Jan 09; 20(2):159-70. PubMed ID: 16511408
    [Abstract] [Full Text] [Related]

  • 4. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
    Izopet J, Marchou B, Charreau I, Sauné K, Tangre P, Molina JM, Aboulker JP, Window (ANRS 106) Study Team.
    Antivir Ther; 2008 Jan 09; 13(4):537-45. PubMed ID: 18672532
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
    Pérez-Alvarez L, Carmona R, Muñoz M, Delgado E, Thomson MM, Contreras G, Pedreira JD, Rodríguez Real R, Vázquez de Parga E, Medrano L, Taboada JA, Nájera R, Spanish Group for Antiretroviral Resistance Studies in Galicia.
    Antivir Ther; 2003 Aug 09; 8(4):355-60. PubMed ID: 14518705
    [Abstract] [Full Text] [Related]

  • 8. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
    Bellocchi MC, Forbici F, Palombi L, Gori C, Coelho E, Svicher V, D'Arrigo R, Emberti-Gialloreti L, Ceffa S, Erba F, Marazzi MC, Silberstein FC, Perno CF.
    J Med Virol; 2005 Aug 09; 76(4):452-8. PubMed ID: 15977236
    [Abstract] [Full Text] [Related]

  • 9. Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.
    Gonsalez CR, Alcalde R, Nishiya A, Barreto CC, Silva FE, de Almeida A, Mendonça M, Ferreira F, Fernandes SS, Casseb J, Duarte AJ.
    Virus Res; 2007 Nov 09; 129(2):87-90. PubMed ID: 17686543
    [Abstract] [Full Text] [Related]

  • 10. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B, García F, Gutierrez C, Martinez-Picado J, Aguilera A, Saumoy M, Vallejo A, Domingo P, Dalmau D, Ribas MA, Blanco JL, Pedreira J, Perez-Elias MJ, Leal M, de Mendoza C, Soriano V, Red de Investigación en SIDA.
    J Med Virol; 2005 Sep 09; 77(1):23-8. PubMed ID: 16032728
    [Abstract] [Full Text] [Related]

  • 11. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.
    J Med Virol; 2004 Jul 09; 73(3):350-61. PubMed ID: 15170628
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
    Peuchant O, Thiébaut R, Capdepont S, Lavignolle-Aurillac V, Neau D, Morlat P, Dabis F, Fleury H, Masquelier B, ANRS CO3 Aquitaine Cohort.
    AIDS; 2008 Jul 31; 22(12):1417-23. PubMed ID: 18614864
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
    Muñoz M, Carmona R, Pérez-Alvarez L, Cilla G, Suarez MD, Delgado E, Contreras G, Corral J, de Goicoetxea MJ, Medrano L, Lezaún MJ, Nájera R, Spanish Group for Antiretroviral Resistance Studies in Basque Country.
    J Clin Virol; 2005 Jul 31; 33(3):224-9. PubMed ID: 15911444
    [Abstract] [Full Text] [Related]

  • 19. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S, Zazzi M, Corsi P, Gonnelli A, Di Pietro M, Giacometti A, Almi P, Trezzi M, Boeri E, Gianotti N, Menzo S, Del Gobbo R, Francisci D, Nerli A, Galli L, De Luca A, Antiretroviral Resistance Cohort Analysis Study Group.
    Antivir Ther; 2009 Jul 31; 14(3):359-69. PubMed ID: 19474470
    [Abstract] [Full Text] [Related]

  • 20. Long-term immunologic and virologic responses in patients with highly resistant HIV infection who are treated with an incompletely suppressive antiretroviral regimen.
    Gandhi T, Nagappan V, Cinti S, Wei W, Kazanjian P.
    Clin Infect Dis; 2007 Oct 15; 45(8):1085-92. PubMed ID: 17879930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.